查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609122

黴漿菌測試市場：按產品/服務、技術、應用和最終用戶分類 - 全球預測 2025-2030 年

Mycoplasma Testing Market by Product & Service (Assays, Kits, & Reagents, Instruments, Services), Technique (Direct DNA Staining, Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年黴漿菌檢測市場價值為10億美元，預計2024年將達10.8億美元，複合年成長率為8.29%，預計2030年將達到17.5億美元。

黴漿菌檢測透過檢測可能損害產品品質和病人安全的污染，在確保生技藥品、疫苗和細胞療法的安全性和有效性方面發揮關鍵作用。這種需求源自於製藥和生技產業嚴格的監管要求和品質保證標準，推動了對可靠測試解決方案的需求。主要應用包括細胞培養和疫苗製造，其中污染可能導致批次失敗和巨大的財務損失。最終用途包括製藥公司、研究機構、委託研究組織等。慢性病的增加、生物製藥製造的進步以及對個人化醫療的日益關注對市場成長產生了重大影響。此外，基於 PCR 的技術和測試程序自動化等技術進步也帶來了潛在的成長機會。次世代定序(NGS) 和就地檢驗的創新可以為相關人員提供競爭優勢。然而，挑戰仍然存在，例如先進檢測工具的高成本、處理不同黴漿菌物種的複雜性以及地區之間嚴格的監管環境，這些環境可能會阻礙市場擴張。為了抓住新的機遇，公司必須投資研發，以開發具有成本效益、快速且靈敏的檢測方法。與生物技術公司和研究機構的合作也可以支持技術進步。關鍵是要集中精力進行地理擴張，以開拓開拓的市場，並保持對不同地區監管機構的嚴格遵守。總體而言，黴漿菌檢測市場本質上正在快速發展，強調準確性和技術整合，為技術創新提供了有吸引力的空間。優先領域包括開發方便用戶使用的快速檢測套件和自動化系統，它們有可能從根本上改變測試通訊協定並提高效率和可靠性。在這些領域競爭考察的策略投資可以產生顯著的長期效益並推動競爭優勢。

主要市場統計
基準年[2023] 10億美元
預計年份 [2024] 10.8億美元
預測年份 [2030] 17.5億美元
複合年成長率（%） 8.29%

市場動態：快速發展的黴漿菌檢測市場的關鍵市場洞察

黴漿菌檢測市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 黴漿菌相關疾病增加
    • 生物技術和製藥行業對品管的需求不斷增加
    • 黴漿菌檢測在細胞培養和疫苗生產中的重要性日益增加
  • 市場限制因素
    • 昂貴的診斷技術，僅適用於有限的技術人員
  • 市場機會
    • 透過與黴漿菌檢測中的人工智慧和機器學習相結合，增強資料分析和結果解釋
    • 高通量檢測和減少手動錯誤的自動化開發
  • 市場挑戰
    • 確保不斷進化的黴漿菌菌株的測試性能一致

波特五力戰略工具駕馭黴漿菌檢測市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解黴漿菌偵測市場的外部影響

外部宏觀環境因素在塑造黴漿菌檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解黴漿菌偵測市場的競爭狀況

對黴漿菌測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣黴漿菌偵測市場供應商績效評估

FPNV 定位矩陣是評估黴漿菌測試市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製黴漿菌檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，黴漿菌測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 黴漿菌相關疾病的傳播
      • 生物技術和製藥行業對品管的需求不斷增加
      • 黴漿菌檢測在細胞培養和疫苗生產中的重要性日益增加
    • 抑制因素
      • 診斷技術昂貴且專業知識有限。
    • 機會
      • 將人工智慧和機器學習整合到黴漿菌測試中可增強資料分析和結果解釋
      • 開發高通量測試自動化並減少手動錯誤
    • 任務
      • 確保不斷進化的黴漿菌菌株的測試性能一致
  • 市場區隔分析
    • 使用 PCR 技術進行黴漿菌檢測，以獲得快速、準確的臨床結果
    • 製藥和生物技術領域擴大採用黴漿菌檢測來開發細胞療法
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章黴漿菌檢測市場：依產品及服務分類

  • 測定、套件和試劑
  • 裝置
    • DNA定序儀
    • 酵素連結免疫吸附測定儀
    • 螢光顯微鏡
    • PCR系統
  • 服務
    • 認證和檢驗服務
    • 諮詢服務
    • 測試服務

第7章黴漿菌檢測市場：依技術分類

  • 直接DNA染色
  • 酵素免疫分析法
  • 核酸檢測
  • 聚合酵素鏈鎖反應

第8章黴漿菌檢測市場：依應用分類

  • 細胞株測試
  • 藥物發現與開發
  • 病毒測試

第9章黴漿菌檢測市場：依最終用戶分類

  • 學術研究所
  • 細胞庫和實驗室
  • 合約調查機構
  • 製藥和生物技術公司

第10章美洲黴漿菌檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區黴漿菌檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲黴漿菌檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • AnaBioTec 和 BioMerieux 透過先進的 NAT 技術和全面的檢驗服務徹底改變了黴漿菌測試
    • QIAGEN 推出全新 QIAcuity 數位 PCR套件，以提高安全檢測解決方案的準確性和效率
  • 戰略分析和建議

公司名單

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, Inc.
  • Bionique Testing Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Genecopoeia, Inc.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Minerva Biolabs GmbH
  • MP Biomedicals, LLC
  • Mycoplasma Experience Limited
  • Nelson Laboratories Fairfield, Inc.
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Savyon Diagnostics
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Wuxi AppTec
Product Code: MRR-FB6C9E7934EF

The Mycoplasma Testing Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.08 billion in 2024, and is projected to grow at a CAGR of 8.29%, to USD 1.75 billion by 2030.

Mycoplasma testing plays a crucial role in ensuring the safety and efficacy of biologics, vaccines, and cell-based therapies by detecting contamination, which could compromise product quality and patient safety. Necessity arises from stringent regulatory requirements and quality assurance standards in pharmaceuticals and biotechnology industries, propelling demand for reliable testing solutions. Key applications include cell culture and vaccine production, where any contamination can lead to batch failures and substantial financial loss. End-use scope encompasses pharmaceutical companies, research institutes, and contract research organizations. Market growth is predominantly influenced by the increasing prevalence of chronic diseases, advancements in biopharmaceutical production, and a rising focus on personalized medicine. Furthermore, technological advancements such as PCR-based methods and automation in testing procedures present potential opportunities for growth. Innovations in next-generation sequencing (NGS) and point-of-care testing can provide competitive advantages to stakeholders. However, challenges persist, including high costs of advanced testing tools, the complexity of dealing with different mycoplasma species, and stringent regulatory landscapes across regions, which may hinder market expansion. To leverage emerging opportunities, businesses must invest in R&D to develop cost-effective, rapid, and highly sensitive detection methods. Collaboration with biotechnology companies and research organizations can also aid in technological advancements. A focused effort on regional expansion to tap into underpenetrated markets and maintaining robust compliance with regulatory bodies across different geographies will be key. Overall, the mycoplasma testing market by nature is rapidly evolving, with an emphasis on precision and technological integration, presenting an attractive space for innovation. Priority areas include the development of user-friendly, rapid detection kits and automated systems, which could radically transform testing protocols and improve efficiency and reliability. Insight-driven strategic investment in these areas could harness significant long-term gains and drive the competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 1.00 billion
Estimated Year [2024] USD 1.08 billion
Forecast Year [2030] USD 1.75 billion
CAGR (%) 8.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mycoplasma Testing Market

The Mycoplasma Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of mycoplasma related diseases
    • Rising demand for quality control in biotechnology and pharmaceutical industry
    • Growing importance of mycoplasma testings in cell culture and vaccine production
  • Market Restraints
    • Expensive diagnostics technique and limited availability of technical experties
  • Market Opportunities
    • Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
    • Development of automation for high throughput testings and reducing manual errors
  • Market Challenges
    • Ensuring consistent performance of test among evolving mycoplasma strains

Porter's Five Forces: A Strategic Tool for Navigating the Mycoplasma Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mycoplasma Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mycoplasma Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mycoplasma Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mycoplasma Testing Market

A detailed market share analysis in the Mycoplasma Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mycoplasma Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mycoplasma Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mycoplasma Testing Market

A strategic analysis of the Mycoplasma Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mycoplasma Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioFire Diagnostics, Inc., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genecopoeia, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Meridian Bioscience, Inc., Minerva Biolabs GmbH, MP Biomedicals, LLC, Mycoplasma Experience Limited, Nelson Laboratories Fairfield, Inc., Norgen Biotek Corporation, Promocell GmbH, Savyon Diagnostics, Takara Bio Inc., Thermo Fisher Scientific, Inc., and Wuxi AppTec.

Market Segmentation & Coverage

This research report categorizes the Mycoplasma Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Assays, Kits, & Reagents, Instruments, and Services. The Instruments is further studied across DNA Sequencers, ELISA Readers, Fluorescent Microscopes, and PCR Systems. The Services is further studied across Certification & Validation Services, Consulting Services, and Testing Services.
  • Based on Technique, market is studied across Direct DNA Staining, Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing, and Polymerase Chain Reaction.
  • Based on Application, market is studied across Cell Line Testing, Drug Discovery & Development, and Virus Testing.
  • Based on End-User, market is studied across Academic & Research Institutes, Cell Banks & Laboratories, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of mycoplasma related diseases
      • 5.1.1.2. Rising demand for quality control in biotechnology and pharmaceutical industry
      • 5.1.1.3. Growing importance of mycoplasma testings in cell culture and vaccine production
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive diagnostics technique and limited availability of technical experties
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
      • 5.1.3.2. Development of automation for high throughput testings and reducing manual errors
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring consistent performance of test among evolving mycoplasma strains
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Usage of PCR techniques in mycoplasma testings for rapid and precise clinical results
    • 5.2.2. Rising adoption of mycoplasma testings in pharmaceutical & biotechnology sectors for cell therapy development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mycoplasma Testing Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
    • 6.3.1. DNA Sequencers
    • 6.3.2. ELISA Readers
    • 6.3.3. Fluorescent Microscopes
    • 6.3.4. PCR Systems
  • 6.4. Services
    • 6.4.1. Certification & Validation Services
    • 6.4.2. Consulting Services
    • 6.4.3. Testing Services

7. Mycoplasma Testing Market, by Technique

  • 7.1. Introduction
  • 7.2. Direct DNA Staining
  • 7.3. Enzyme-Linked Immunosorbent Assay
  • 7.4. Nucleic Acid Testing
  • 7.5. Polymerase Chain Reaction

8. Mycoplasma Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Line Testing
  • 8.3. Drug Discovery & Development
  • 8.4. Virus Testing

9. Mycoplasma Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Cell Banks & Laboratories
  • 9.4. Contract Research Organizations
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Mycoplasma Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mycoplasma Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Mycoplasma Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. AnaBioTec and bioMerieux revolutionize mycoplasma testing with advanced NAT technologies and comprehensive validation services
    • 13.3.2. QIAGEN launches new QIAcuity digital PCR kits, enhancing accuracy and efficiency of safety testing solutions
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam plc
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BioFire Diagnostics, Inc.
  • 5. Bionique Testing Laboratories, Inc.
  • 6. Charles River Laboratories International, Inc.
  • 7. Creative Bioarray
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche AG
  • 10. Genecopoeia, Inc.
  • 11. InvivoGen
  • 12. Lonza Group Ltd.
  • 13. Merck KGaA
  • 14. Meridian Bioscience, Inc.
  • 15. Minerva Biolabs GmbH
  • 16. MP Biomedicals, LLC
  • 17. Mycoplasma Experience Limited
  • 18. Nelson Laboratories Fairfield, Inc.
  • 19. Norgen Biotek Corporation
  • 20. Promocell GmbH
  • 21. Savyon Diagnostics
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific, Inc.
  • 24. Wuxi AppTec

LIST OF FIGURES

  • FIGURE 1. MYCOPLASMA TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. MYCOPLASMA TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MYCOPLASMA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MYCOPLASMA TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DNA SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ELISA READERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY FLUORESCENT MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CERTIFICATION & VALIDATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DIRECT DNA STAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL LINE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY VIRUS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL BANKS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023